Showing results (571-580 of 652) with videos related to
Sort By:
Pageof 66
Frontiers in Medicine|August 6, 2019
Novel Microbial-Based Immunotherapy Approach for Crohn's DiseaseSimon Sutcliffe, Shirin Kalyan, Jim Pankovich, et al.Current Neuropharmacology|January 10, 2014
Neurodevelopment in schizophrenia: the role of the wnt pathwaysIsabella Panaccione, Flavia Napoletano, Alberto Maria Forte, et al.Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.Current Neuropharmacology|March 2, 2013
The wnt pathway in mood disordersGabriele Sani, Flavia Napoletano, Alberto Maria Forte, et al.Fungal Ecology|December 25, 2019
Diversity and function of fungi associated with the fungivorous millipede, <i>Brachycybe lecontii</i>Angie M Macias, Paul E Marek, Ember M Morrissey, et al.Gastroenterology|February 8, 2022
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 StudyWilliam J Sandborn, Geert R D'Haens, Walter Reinisch, et al.United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.BMC Medical Genetics|October 16, 2020
Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjectsWilliams Turpin, Larbi Bedrani, Osvaldo Espin-Garcia, et al.Inflammatory Bowel Diseases|January 30, 2025
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative ColitisTarun Chhibba, Alexandra Frolkis, Levi R Stein, et al.Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.Pageof 66